Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Prados

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Acta Diabetologica|January 31, 2025
Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1cI Aguilera García, B Barquiel Alcalá, P Vázquez Pérez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Evolution of lipid profiles in long-term peritoneal dialysisJ Olivares, C Cruz, J M Gas, et al.
Contributions to Nephrology|January 1, 1991
CAPD with three bag exchanges and one day rest. Results of a new protocolJ P Contreras, J M Gas, M C Prados, et al.
Contributions to Nephrology|January 1, 1991
CAPD in EuropeJ Olivares, J M Gas, M C Prados, et al.
The International Journal of Biological Markers|April 14, 2004
How to express tumor markers in bronchoalveolar lavageF J Gómez de Terreros Caro, R Alvarez-Sala, M C Prados, et al.
Cancer|September 1, 1994
The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavageM C Prados, R Alvarez-Sala, R Blasco, et al.
Clinical Nutrition ESPEN|April 10, 2026
TRIGLYCERIDE-RELATED LIPID CHANGES IN ADULTS WITH CYSTIC FIBROSIS TREATED WITH ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: A REAL-WORLD CROSS-SECTIONAL STUDYE Zamarrón, A Pérez Cuadrado, L Baloira, et al.
Diabetes Research and Clinical Practice|October 21, 2025
Continuous Glucose Monitoring as an alternative for Cystic Fibrosis Related diabetes screening and diagnosisI Aguilera García, P Vázquez Pérez, B López Plaza, et al.
Rheumatology (Oxford, England)|October 1, 2024
The real-world use and effectiveness of avacopan in routine practice for the treatment of ANCA vasculitis. First experiences in SpainJuliana Draibe, Georgina Espigol-Frigolé, Maria Cinta Cid, et al.
Diabetes Research and Clinical Practice|August 26, 2024
Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practiceI Aguilera García, R M García Moreno, B López Plaza, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Diabetologica|January 31, 2025
Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1cI Aguilera García, B Barquiel Alcalá, P Vázquez Pérez, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1992
Evolution of lipid profiles in long-term peritoneal dialysisJ Olivares, C Cruz, J M Gas, et al.
Contributions to Nephrology|January 1, 1991
CAPD with three bag exchanges and one day rest. Results of a new protocolJ P Contreras, J M Gas, M C Prados, et al.
Contributions to Nephrology|January 1, 1991
CAPD in EuropeJ Olivares, J M Gas, M C Prados, et al.
The International Journal of Biological Markers|April 14, 2004
How to express tumor markers in bronchoalveolar lavageF J Gómez de Terreros Caro, R Alvarez-Sala, M C Prados, et al.
Cancer|September 1, 1994
The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavageM C Prados, R Alvarez-Sala, R Blasco, et al.
Clinical Nutrition ESPEN|April 10, 2026
TRIGLYCERIDE-RELATED LIPID CHANGES IN ADULTS WITH CYSTIC FIBROSIS TREATED WITH ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: A REAL-WORLD CROSS-SECTIONAL STUDYE Zamarrón, A Pérez Cuadrado, L Baloira, et al.
Diabetes Research and Clinical Practice|October 21, 2025
Continuous Glucose Monitoring as an alternative for Cystic Fibrosis Related diabetes screening and diagnosisI Aguilera García, P Vázquez Pérez, B López Plaza, et al.
Rheumatology (Oxford, England)|October 1, 2024
The real-world use and effectiveness of avacopan in routine practice for the treatment of ANCA vasculitis. First experiences in SpainJuliana Draibe, Georgina Espigol-Frigolé, Maria Cinta Cid, et al.
Diabetes Research and Clinical Practice|August 26, 2024
Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practiceI Aguilera García, R M García Moreno, B López Plaza, et al.
Pageof 3